{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:20:28Z","timestamp":1774416028738,"version":"3.50.1"},"reference-count":53,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.1080\/14712598.2020.1789096","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T01:23:33Z","timestamp":1593221013000},"page":"915-922","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Antibody\u2013drug conjugates for the treatment of urothelial carcinoma"],"prefix":"10.1080","volume":"21","author":[{"given":"Praful","family":"Ravi","sequence":"first","affiliation":[{"name":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley A.","family":"McGregor","sequence":"additional","affiliation":[{"name":"Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"cit0002","unstructured":"Cancer Stat Facts - Bladder Cancer. SEER Program. cited 2020 Apr 15. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.350"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022148"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.04.006"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24466"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.5548"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.17.3068"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.8433"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3571"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613683"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33297-X"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0084"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.5534"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-018-0380-1"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817323"},{"key":"cit0017","unstructured":"[cited 2020 Apr 15]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-enfortumab-vedotin-ejfv-metastatic-urothelial-cancer"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2394"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.435"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-014-1763-4"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1313"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02044"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-019-00844-x"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01140"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4599"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.6_suppl.441"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1369\/0022155411410430"},{"key":"cit0028","unstructured":"[cited 2020 May 1]. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-grants-accelerated-approval-sacituzumab-govitecan-hziy-metastatic-triple-negative-breast-cancer"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17407"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.354"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.5858\/2010-0454-RAR.1"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32417-5"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1038\/nature12965"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1038\/srep42713"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.0994"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.10.009"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.66.3468"},{"key":"cit0038","unstructured":"[cited 2020 May 1]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/125427s105lbl.pdf"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.05.087"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.2502"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-015-3503-3"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.4509"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30328-6"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914510"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0749"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0570"},{"issue":"6","key":"cit0047","first-page":"266","volume":"27","author":"Petrylak D","year":"2016","journal-title":"Ann Oncol"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23240"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30859-3"},{"key":"cit0050","unstructured":"[cited 2020 May 1]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pembrolizumab-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer"},{"issue":"7","key":"cit0051","first-page":"2837","volume":"9","author":"Di Paolo C","year":"2003","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.07.020"},{"key":"cit0053","unstructured":"Dickstein R, Wu N, Cowan B, et al. VISTA, phase 3 trial of Vicinium, an EpCAM-targeted pseudomonas exotoxin, in BCG-unresponsive non-muscle invasive bladder cancer. [cited 2020 May 1]. Available from: https:\/\/sesenbiocom\/wp-content\/uploads\/2019\/01\/BLADDR_Congress_2018_Posterlpdf"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2020.1789096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T10:06:17Z","timestamp":1624269977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2020.1789096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,3]]}},"alternative-id":["10.1080\/14712598.2020.1789096"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2020.1789096","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}